Results 101 to 110 of about 97,860 (303)

Die NP het geen plan nie

open access: yes, 1994
462.B.1.3(16).pdf created from the media publications in the SA Election material Collection MS 462, held in the Manuscripts Section of the Stellenbosch Library and Information Service.Die NP het geen plan nie. 1994.

core  

Autoimmune neutropenia in children: Test cells versus beads and a role for pro‐LL‐37 and absolute neutrophil count

open access: yesBritish Journal of Haematology, EarlyView.
A comparison between bead‐based and cell‐based assays for autoantibody detection in childhood neutropenia revealed substantial discordance between platforms. Bead‐based methods should be complemented with cell‐based methods for optimal diagnostic sensitivity. Incorporating pro‐LL‐37 and ANC measurements into the clinical workup of childhood neutropenia
Paul Ratcliffe   +3 more
wiley   +1 more source

Unite the people of the Cape

open access: yes, 1994
462.B.1.3(49).pdf created from the media publications in the SA Election material Collection MS 462, held in the Manuscripts Section of the Stellenbosch Library and Information Service.Unite the people of the Cape. 1994.

core  

ANC-related characteristics, Hargeisa, September 2022.

open access: yes
ANC-related characteristics, Hargeisa, September 2022.
Abdeta Muktar Ahmed (18404425)   +2 more
core   +1 more source

Estimated pulse wave velocity as a marker of major adverse cardiovascular events in essential thrombocythaemia and polycythaemia vera

open access: yesBritish Journal of Haematology, EarlyView.
In patients with essential thrombocythaemia or polycythaemia vera, higher estimated pulse wave velocity (ePWV) was independently associated with major adverse cardiovascular events, while its relationship with overall survival was largely age‐driven.
Alessandro Costa   +6 more
wiley   +1 more source

A phase IIa study of the anti‐PD‐L1 antibody avelumab in relapsed/refractory PTCL: The AVAIL‐T trial

open access: yesBritish Journal of Haematology, EarlyView.
The AVAIL‐T study, the first evaluation of programmed death ligand 1 (PD‐L1) blockade in relapsed/refractory peripheral T‐cell lymphomas (PTCL), demonstrated limited single agent activity with durable responses seen in a minority. Circulating tumour DNA revealed distinct mutational dynamics and mass cytometry identified perturbed T‐cell subsets ...
Matthew J. Ahearne   +28 more
wiley   +1 more source

A Composite Maternal Healthcare Index and Its Determinants in Ethiopia: A Multilevel Analysis of Mini‐DHS 2019 [PDF]

open access: yesPublic Health Chall
Using 2019 Ethiopia Mini‐DHS data, we developed a composite maternal healthcare utilization index and found substantial socioeconomic and geographic disparities. Higher education, household wealth, and urban residence were associated with higher utilization, whereas postnatal care showed the weakest contribution, highlighting an important gap in the ...
Aga M, Chen D.
europepmc   +2 more sources

The whole world wants to see a change

open access: yes, 1994
462.B.1.3(48).pdf created from the media publications in the SA Election material Collection MS 462, held in the Manuscripts Section of the Stellenbosch Library and Information Service.The whole world wants to see a change. 1994.

core  

We cannot afford more of this

open access: yes, 2023
462.B.1.3(60).pdf created from the media publications in the SA Election material Collection MS 462, held in the Manuscripts Section of the Stellenbosch Library and Information Service.Newspaper advertisement by the African National Congress (ANC ...

core  

CAR‐HEMATOTOX score to predict risk of poor outcomes with odronextamab in heavily pretreated B‐cell non‐Hodgkin lymphoma

open access: yesBritish Journal of Haematology, EarlyView.
High versus low baseline CAR‐HEMATOTOX scores were associated with poorer safety and efficacy outcomes in patients with R/R B‐NHL who received odronextamab in the ELM‐1 and ELM‐2 studies. The CAR‐HEMATOTOX score may provide a readily available measure for identifying patients at risk of inferior clinical outcomes with odronextamab treatment.
Matthew Matasar   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy